Cargando…
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis
OBJECTIVE: Gut dysbiosis contributes to multiple autoimmune diseases, including ankylosing spondylitis, which is commonly treated with tumor necrosis factor (TNF)-α inhibitors (TNFis). Because host TNF-α levels are considered to interact with gut microbiota, we aimed to systematically investigate th...
Autores principales: | Dai, Qinghong, Xia, Xuyang, He, Chenjia, Huang, Yupeng, Chen, Yidan, Wu, Yang, Chen, Yuehong, Hou, Qianqian, Shu, Yang, Zhang, Wei, Xu, Heng, Yin, Geng, Xie, Qibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351697/ https://www.ncbi.nlm.nih.gov/pubmed/35852868 http://dx.doi.org/10.1097/FPC.0000000000000468 |
Ejemplares similares
-
Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice
por: Liu, Bin, et al.
Publicado: (2019) -
Gut Microbiota and Inflammatory Cytokine Changes in Patients with Ankylosing Spondylitis
por: Liu, Bin, et al.
Publicado: (2022) -
Swan-neck hands in a patient with ankylosing spondylitis
por: Yidan, Chen, et al.
Publicado: (2019) -
Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010) -
Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021)